The following companies meet the definition of 'substantially affected organizations' (SAO) even though they are not identified as such on the Dun & Bradstreet (D&B) listing (see List of SAOs and description of how SAOs are identified).
If an IC Ethics Official identifies a questionable entity and suggests inclusion on the SAO list, send sufficient information about the entity, including rationale for why it should be considered an SAO, to your assigned NEO Specialist for a determination. Confirmed entities will be added to this list. If an entity has additional information available, the name is linked to the other information.
Format: Entity Name (Date added to list - Month/Year)
| 23andMe (ME) (12/21) | Mahana Therapeutics (3/22) |
| AbbVie (3/13) | Manhattan Scientifics Inc (MHTX) (03/17) |
| Acordia Therapeutics, Inc. (6/14) | Medtronics (8/11) |
| Acceleron Pharma (11/18) | Merus Labs International (Norgine BV) (MSLI) (12/18) |
| Affymetrix (11/06) | MilliporeSigma (formerly known as EMD Millipore) (7/19) |
| Allakos, Inc (11/18) | Mind Medicine, Inc. (MNMD) (4/22) |
| Anacore Pharmaceuticals, Inc. (6/14) | Mindray Medical International Ltd (7/09) |
| Anavo Therapeutics (11/23) | MST Medical Surgery Technologies, Inc. (8/13) |
| Applied DNA Sciences (APDN) (12/21) | Nano-X Imaging Ltd. (NNOX) (4/21) |
| argenx SE (ARGX) (5/20) | Neogenomics, Inc. (NEO) (3/20) |
| Aurinia Pharmaceutical Inc. (AUPH) (4/22) | NOVENESIS (10/24) |
| Avita Medical Limited (2/20) | NovoCure Limited (NVCR) (6/21) |
| Baxalta, Inc (Shire Plc) (12/18) | ObsEva SA (OBSV) (4/20) |
| Bayer Aktiengesellschaft (8/19) | Oncology Pharma, Inc. (ONPH) (3/22) |
| BioLineRx (BLRX) (4/21) | Pacific Biosciences (4/13) |
| Bio-Rad Laboratories (8/06) | PainReform Ltd. (11/22) |
| Bio-Reference Laboratories (3/08) | PharmEnable (8//22) |
| Bionano Genomics, Inc. (BNGO) (4/21) | Photovac (4/06) |
| BioNTech (BNTX) (11/21) | Portilla Pharmaceuticals (6/14) |
| Braxia Scientific Corp. (BRAXF) (1/24) | Prana Biotechnology (3/12) |
| Capstan Therapeutics (4/23) | Procter & Gamble Company (P&G) (7/19) |
| Cardinal Health (CAH) (5/16) | Propanc Biopharm, Inc. (PPCH) (11/18) |
| Check Cap LTD (CHEK) | ProQR Therapeutics N.V. (2/15) |
| China Medical Technologies (2/10) | Qiagen (8/08) |
| Clovis Oncology (4/23) | QLT Inc, Vancouver, Canada (5/10) |
| CRISPR Therapeutics (CRSP) (4/21) | ReceptoPharm (12/18) |
| Darwin Biosciences (11/24) | Relief Therapeutics Holding SA (RLFTF) (4/21) |
| DNAPrint Genomics, Inc. (5/11) | Sagent Pharmaceuticals, Inc. (5/14) |
| Elysium Therapeutics, Inc. (6/13) | Seagen, Inc. (SGEN) (6/21) |
| EssilorLuxottica (ESLOY) (8/21) | Shenzhen Mindray Biomedical Electronics (7/09) |
| FlexBioTech (3/23) | Smith & Nephew (8/10) |
| FSD Pharma Inc. (HUGE) (4/23) | Surgivision (4/06) |
| Galena (GALE) Biopharma, Inc. (7/13) | Symmetry Medical (4/07) |
| GeneDx (2/10) | TaiMed Biologics (12/18) |
| General Electric Capital (GEH) (11/18) | Taysha Gene Therapies (TSHA) (1/22) |
| General Electric HealthCare (GEHC) (2/23) | Techniplast, USA (10/07) |
| Generex Biotechnology Crop (5/11) | Tekla Healthcare Opportunities (7/14) |
| Given Imaging (5/06) | Tekmira Pharmaceuticals (8/14) |
| GW Pharmaceuticals (09/13) | The Institute for In Vitro Sciences, Inc (7/22) |
| Healthpure, Inc. (05/17) | The McConnell Group (10/07) |
| Hospira (4/13) | TomoTherapy (7/08) |
| Hypermarcas S.A. (3/15) | Transgenomic (2/12) |
| IQVIA - formerly Quintiles IMS Holdings Inc (IVQ) (12/18) | Trinity Biotech (10/14) |
| Illumina Inc. (6/14) | Unimicro Technologies (7/08) |
| Immunotech Laboratories (IMBB) (12/18) | Viataris Inc. (VTRS) (4/21) |
| InMode (INMD) (11/21) | VolitionRX (VNRX) (4/21) |
| Isarna Therapeutics (5/14) | Waters Corp. (WAT) (12/24) |
| Kenvue (KVUE) (8/24) | West Pharmaceutical Services, Inc. (3/23) |
| Kinetic Concepts, Inc. (6/09) | World Precision Instruments (10/07) |
| Lab Products, Inc (10/07) | Wuxi Pharma Tech (4/14) |
| Lannett Co. Inc (LCI) (12/18) |
Updated: 3/7/2025
SAO Links:
- Introduction
- General Guidance About SAOs
- Sector Funds
- List of Substantially Affected Organizations (SAOs)
- List of Non-SAOs
- North American Industrial Classification System (NAICS) Codes
For additional information, contact your IC's Deputy Ethics Counselor or Ethics Coordinator.